From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders
about
A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric ResearchA New Outlook on Mental Illnesses: Glial Involvement Beyond the GlueDepression as a Glial-Based Synaptic DysfunctionEffects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell functionFunctional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetNeuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatryCaffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's diseaseConceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depressionRegulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction.Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressantsChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice.Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.Psychiatric disorders: diagnosis to therapyDecreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Disturbance of the glutamatergic system in mood disorders.Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineageGlutamate metabolism in major depressive disorderPrefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.Pathogenesis of depression: Insights from human and rodent studies.Antidepressants Impact Connexin 43 Channel Functions in Astrocytes.Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task.Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.Translational potential of astrocytes in brain disorders.Pharmacological modulation of astrocytes and the role of cell type-specific histone modifications for the treatment of mood disordersHuman dermal fibroblasts in psychiatry research.Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants.LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells.Targeting glutamate signalling in depression: progress and prospects.Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.Bi-phasic regulation of glycogen content in astrocytes via Cav-1/PTEN/PI3K/AKT/GSK-3β pathway by fluoxetine.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases.Aquaporin-4 knockout exacerbates corticosterone-induced depression by inhibiting astrocyte function and hippocampal neurogenesis.Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.An astroglial basis of major depressive disorder? An overview.Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.
P2860
Q26770097-9B240F17-B9F8-429A-9815-7859EEBA9B72Q26770756-16705727-F7FB-4997-94B5-6DBA5DEC8D12Q26772830-FED21565-0CBB-413D-A751-169CD29FE578Q26783101-DDD91560-4C17-4C8E-BAAF-57B4B8BE2555Q26798948-41B93E34-700D-44F8-9DC6-64FAEDDB1024Q26825959-ACF20E6B-CDF8-4995-AAAD-9A38E391AE0CQ27324798-B859F257-3841-4B37-960B-871A7CF28B68Q28387085-CF84BED8-5399-4AE6-A1AF-820103689EAEQ28830670-EE852B7F-A459-4CCC-919B-792970C103DFQ30394998-235C6318-978C-4A92-B200-52F5CA3DE58AQ30887852-3999EB7C-FC5D-40FF-9E02-77805FB45534Q30906677-B2F91EC3-EC3D-4A85-8CDC-B431C05392F3Q33677254-840D8F08-20EB-4975-A295-C02E38446C0CQ33712371-E6703703-4427-4B5C-9F81-822DA76A8891Q33922884-E5FDE326-26EE-45AF-9FF5-BEFAF6B4F22DQ34181837-6B5D602C-B6BD-4507-95DD-B1A5C99DC324Q34391633-5072A7BB-E003-4211-B3E9-B95C938204F8Q35149888-975E0FC3-A5C1-40C7-A225-FC8B9E48CD2FQ35655203-3B35B250-EAAD-4D43-8210-4ADD5E14A16CQ35756139-F07EC43D-27E8-4E88-9878-C90C3696C7CFQ35920768-1B778277-79F0-450C-84D6-4530F10C9B82Q36118835-A5647A27-82B3-4550-9CE0-5CABA1F1D63CQ36332597-734091C8-2160-4BC9-85EC-DCD6BB57E489Q36437932-2622E02A-8641-457F-B093-15392F8E571DQ36848303-D7EF86C2-3034-439D-87DA-8139846A1E41Q38512084-36F9082E-FE78-48E5-B154-008EC82A4E3DQ38589482-AB19EA95-C15B-498C-9E88-A2FC69CDADAAQ38619770-29950D3F-3422-4F6C-A550-293FE296DF79Q38726048-8CBECD2A-55BF-4DDB-855A-81A62BBA3DD4Q38730189-3A935C59-2715-4E8F-8B88-AB6D62BE2283Q38740011-828A5CA5-D5B5-45B1-8B8D-81F0E47F2D58Q38743867-B81D53AB-00FD-4903-B571-9E0D8847DA61Q38875865-FC5B818F-FA67-44D1-80DB-2F58A9D1FFC2Q38944925-87742D0E-6876-4527-B759-1018CEAB0DBFQ38954648-59F3EB89-DBD9-43E1-A3BD-671B207D9405Q38954921-73C6AAD2-8D08-40C5-A6FB-5C4235406E84Q39034588-EA2DE24C-E59B-4453-AC0D-D18A28909ACFQ39124105-663987A5-A035-4335-9283-441FCF623B4CQ39186841-F7E388C2-D6DA-47E2-AE1D-3BFC6CD00842Q40127644-84C950E9-EC43-406C-984A-0683BE9561A3
P2860
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
From pathophysiology to novel ...... nd treatment of mood disorders
@en
type
label
From pathophysiology to novel ...... nd treatment of mood disorders
@en
prefLabel
From pathophysiology to novel ...... nd treatment of mood disorders
@en
P2860
P1476
From pathophysiology to novel ...... nd treatment of mood disorders
@en
P2093
Gerard Sanacora
Mounira Banasr
P2860
P304
P356
10.1016/J.BIOPSYCH.2013.03.032
P407
P577
2013-06-01T00:00:00Z